December 23, 2024 11:32 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
I don't blame Allu Arjun, ready to withdraw case: Pushpa 2 stampede victim's husband | Indian New Wave Cinema Architect Shyam Benegal dies at age 90 | Cylinder blast at a temple in Karnataka's Hubbali injures nine people | Kuwait PM personally sees off Modi at airport as Indian premier concludes two-day trip | Three pro-Khalistani terrorists, who attacked a police outpost in Gurdaspur, killed in an encounter | Who is Sriram Krishnan, an Indian-American picked by Donald Trump as US AI policy advisor? | Mohali building collapse: Death toll rises to 2, many feared trapped for 17 hours | 4-year-old killed after speeding car driven by a teen hits him in Mumbai | PM Modi attends opening ceremony of Arabian Gulf Cup in Kuwait | Jaipur gas tanker crash: Toll touches 14, 30 critical
AstraZeneca's COVID-19 vaccine trial to resume in US

AstraZeneca's COVID-19 vaccine trial to resume in US

Oct 24, 2020, at 03:28 pm

Washington/Xinhua: Multinational pharmaceutical company AstraZeneca said on Friday it will resume the trial of its experimental COVID-19 vaccine in the United States, which has been paused since September.

WHO on Johnson&Johnson halting COVID vaccine trial: Safety paramount

WHO on Johnson&Johnson halting COVID vaccine trial: Safety paramount

Oct 13, 2020, at 09:16 pm

Moscow/Sputnik: The World Health Organization believes that safety in research is crucial and is pleased to see developers acting by the rules, the WHO spokesperson told Sputnik regarding Johnson&Johnson suspending its vaccine trials.

After Oxford Covid-19 Vaccine trial pause, DCGI sends show-cause notice to Serum Institute

After Oxford Covid-19 Vaccine trial pause, DCGI sends show-cause notice to Serum Institute

Sep 10, 2020, at 04:23 am

New Delhi/IBNS: After pharmaceutical giant AstraZeneca halted the Phase 3 study testing of the Oxford Vaccine against Covid-19, the Drugs Controller General of India (DCGI) on Wednesday issued a show-cause notice to Serum Institute of India (SII) for not informing the central drug regulator about the pause of trials in other countries.

AstraZeneca pauses Covid-19 vaccine trial after suspected adverse reaction seen in participant

AstraZeneca pauses Covid-19 vaccine trial after suspected adverse reaction seen in participant

Sep 09, 2020, at 01:30 pm

London:  Pharmaceutical company AstraZeneca has halted the Phase 3 study testing of a Covid-19 vaccine after a suspected serious adverse reaction was seen in a participant in the United Kingdom, media reports said.